PUTRAJAYA, March 21 (Bernama) — Sponsored clinical research in Malaysia recorded an exceptional performance in 2021, surpassing its previous years accomplishments, as highlighted in Clinical Research Malaysia’s (CRM) Annual Report 2021. The report was launched earlier today by the Minister of Health, YB Khairy Jamaluddin at the Ministry of Health complex in Putrajaya, witnessed by CRM Board of Directors and stakeholders.
The annual report detailed 215 new sponsored clinical research in the country, the highest annual number reported since CRM’s inception. In 2021, Malaysia moved a position up, now ranking second within Southeast Asia region after Singapore, in terms of the number of global industry sponsored studies. These record-high numbers were also reflected in the Gross National Income generated, with highest annual value of RM 226 million investment reported from new sponsored studies, contributing to a cumulative value of RM 834 million generated from sponsored research since 2012.
- World Investment Conference Kicked Off In Riyadh
- Two More Palestinian Boys Shot Dead By Sadistic Zionist Army In N. West Bank
- Update: 16 Still Missing After Safari Boat Sank Off SE Egypt
- Kenya launches 16 Days of Activism against GBV amid rising cases
- UN Envoy Urges More Support For Syria As 400,000 Syrian Refugees Return From Lebanon
- Russia Could Deploy Missiles In Asia If U.S. Missiles Appear There: Deputy FM
- Indonesia To Run Regional Elections Tomorrow
- Lee Hsien Loong Supports Lawrence Wong To Lead Singapore’s Ruling Party
- 18 Killed, Over 30 Injured In Armed Clashes In NW Pakistan
- Iraq Warns Of Possible Israeli Attacks In Letters To UN